BioGaia
113.40 SEK
+2.62 %
Less than 1K followers
BIOG B
NASDAQ Stockholm
Biotechnology & Pharmaceuticals
Health Care
Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Valuation
Income statement
Quarter data
Quarter data
Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for BioGaia
| Q3/24 | Q4/24 | 2024 | Q1/25 | Q2/25 | Q3/25 | Q4/25 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | 304.0 | 364.8 | 1,422.7 | 366.3 | 404.7 | 326.6 | 440.6 | 1,538.2 |
| EBITDA | 99.0 | 110.7 | 500.1 | 103.3 | 114.6 | 92.1 | 127.1 | 437.2 |
| EBIT | 41.4 | 103.4 | 423.4 | 97.1 | 108.4 | 86.0 | 121.0 | 412.5 |
| EBIT-% | 13.6 % | 28.3 % | 29.8 % | 26.5 % | 26.8 % | 26.3 % | 27.5 % | 26.8 % |
| Profit before taxes | 47.0 | 104.5 | 447.8 | 101.9 | 110.4 | 85.3 | 123.6 | 421.2 |
| Net income | 36.6 | 81.9 | 351.4 | 80.2 | 87.9 | 65.9 | 98.8 | 332.8 |